Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Laboratory for Brain-Gut Axis Studies, Katholieke Universiteit Leuven, Leuven, Belgium.
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e64-e73. doi: 10.1016/j.cgh.2020.12.021. Epub 2021 Jan 14.
BACKGROUND & AIMS: Esophageal hypervigilance and anxiety are emerging as important drivers of dysphagia symptoms and reduced quality of life across esophageal diagnoses. The esophageal hypervigilance and anxiety scale (EHAS) is a validated measure of these cognitive-affective processes. However, its length may preclude it from use in clinical practice. We aimed to create a short form version of the EHAS using established psychometric practices.
A retrospective review of a registry of patients who visited a university-based esophageal motility clinic for diagnostic testing was conducted. Patients were included if they completed the 15-item EHAS and questionnaires assessing dysphagia severity and health-related quality of life (HRQOL) at the time of motility testing. Principle components factor analysis identified items for possible removal. Tests for reliability and concurrent validity were performed on the full EHAS and short-form version (EHAS-7).
3,976 adult patients with confirmed esophageal disease were included: 30% with achalasia or EGJOO, 13% with EoE, 13% with GERD, 39% normal motility. Eight items were removed from the scale based on a factor loading of > 0.70, resulting in a single scale 7-item EHAS-7 scored from 0 to 28. The EHAS-7 demonstrated excellent internal consistency (α = 0.91) and split-half reliability (0.88) as was found in the full EHAS in the current study and prior validation. Concurrent validity existed between the EHAS-7 and measures of dysphagia (r = 0.33) and HRQOL (r = -0.73, both P < .001).
The EHAS-7 is a 7-item scale to assess esophageal hypervigilance and symptom-specific anxiety that performs as well as the original 15-item version. Shorter questionnaires allow for implementation in clinical practice. The EHAS-7 is a useful tool for clinicians to quickly assess how hypervigilance and anxiety may be contributing to their patients' clinical presentations.
食管高敏和焦虑正在成为各种食管疾病吞咽困难症状和生活质量降低的重要驱动因素。食管高敏和焦虑量表(EHAS)是一种评估这些认知-情感过程的有效工具。然而,其长度可能使其无法在临床实践中使用。我们旨在使用已建立的心理测量学方法创建 EHAS 的简短形式版本。
对在一所大学食管动力诊所进行诊断性检查的患者登记处进行了回顾性研究。如果患者在进行动力检查时完成了 15 项 EHAS 和评估吞咽困难严重程度和健康相关生活质量(HRQOL)的问卷,则将其纳入研究。主要成分因子分析确定了可能需要删除的项目。对完整的 EHAS 和简短形式版本(EHAS-7)进行了可靠性和同时效性检验。
纳入了 3976 名确诊食管疾病的成年患者:30%为贲门失弛缓症或食管胃连接部运动障碍,13%为嗜酸细胞性食管炎,13%为胃食管反流病,39%为正常动力。根据因子负荷>0.70,量表中删除了 8 个项目,得到一个 7 项的 EHAS-7,评分范围为 0 至 28。在当前研究和先前验证中,EHAS-7 表现出极好的内部一致性(α=0.91)和半分可靠性(0.88)。EHAS-7 与吞咽困难(r=0.33)和 HRQOL(r=-0.73,均 P<0.001)之间存在同时效性。
EHAS-7 是一种评估食管高敏和症状特异性焦虑的 7 项量表,其性能与原始的 15 项版本相同。较短的问卷允许在临床实践中实施。EHAS-7 是临床医生评估高敏和焦虑如何影响患者临床表现的有用工具。